63 participants
A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-06-19
- Start Date:
- 2011-11-06
- Completion:
- 2012-04-03
Conditions
- Prostatic Hyperplasia
Interventions
- DRUG
No Results Yet